A screening algorithm for early detection of major depressive disorder in head and neck cancer patients post‐treatment: Longitudinal study

Henry, Mélissa; Rosberger, Zeev; Ianovski, Lola E.; Hier, Michael P.; Zeitouni, Anthony; Kost, Karen; Mlynarek, Alex; Black, Martin J.; MacDonald, Christina; Richardson, Keith; Zhang, Xun; Führmann, Fabienne; Chartier, Gabrielle; Frenkiel, Saul

doi:10.1002/pon.4705

Cited by 20 publications

(28 citation statements)

References 45 publications

(61 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In total 33 of these articles fulfilled the eligibility criteria. In addition, two studies were included after screening the reference lists, resulting in 35 articles . These 35 articles provided results on 27 separate studies.…”

Section: Resultsmentioning

confidence: 99%

“…In Table , the characteristics of the 35 included studies are described. Twenty‐one studies reported on factors associated with depression at a single time point, 10 studies on factors associated with the course of depression and four on both . Results on factors associated with depression at a single time point and the course of depression are presented separately.…”

Section: Resultsmentioning

confidence: 99%

“…Of the 25 studies that focused on factors associated with depression at a single time point, publication year ranged from 1999 to 2018 . Most studies focused on mixed HNC patients, while four studies focused on nasopharyngeal, oropharyngeal, or oral cancer .…”

Section: Resultsmentioning

confidence: 99%

“…Most studies focused on mixed HNC patients, while four studies focused on nasopharyngeal, oropharyngeal, or oral cancer . The majority measured symptoms of depression, while four studies measured a clinical diagnosis of depression . Symptoms of depression were measured using the Hospital Anxiety and Depression Scale (HADS) depression domain, Center for Epidemiological Studies Depression Scale (CES‐D), Beck Depression Inventory (BDI), self‐rating depression scale (SDS), and the Symptom Checklist (SCL) depression domain .…”

Section: Resultsmentioning

confidence: 99%

“…Symptoms of depression were measured using the Hospital Anxiety and Depression Scale (HADS) depression domain, Center for Epidemiological Studies Depression Scale (CES‐D), Beck Depression Inventory (BDI), self‐rating depression scale (SDS), and the Symptom Checklist (SCL) depression domain . With respect to a clinical diagnosis of depression, two studies extracted data from an insurance database on the International Classification of Diseases (ICD) diagnosis on depression, and two studies used a structured clinical interview to identify the presence of a Diagnostic and Statistical Manual of Mental Disorders (DSM)‐IV diagnosis of depression . Of the included studies, nine measured depression less than or equal to 3 months, 14 studies measured depression 3 to 12 months, and nine studies measured depression less than 1 year after treatment (some performed several analyses).…”

Section: Resultsmentioning

confidence: 99%

See 4 more Smart Citations

Factors associated with depression over time in head and neck cancer patients: A systematic review

et al. 2019

View full text Add to dashboard Cite

Objective To systematically review the literature on factors associated with a clinical diagnosis of depression or symptoms of depression (depression) among head and neck cancer (HNC) patients. Methods The search was conducted in PubMed, PsycINFO, and CINAHL. Studies were included if they investigated factors associated with depression among HNC patients, they were of prospective or longitudinal nature, and English full text was available. The search, data extraction, and quality assessment were performed by two authors. Based on the data extraction and quality assessment, the level of evidence was determined. Results In total, 35 studies were included: 21 on factors associated with depression at a single (later) time point, 10 on the course of depression, and four on both. In total, 77 sociodemographic, lifestyle, clinical, patient‐reported outcome measures, and inflammatory factors were extracted. Regarding depression at a single time point, there was strong evidence that depression at an earlier time point was significantly associated. For all other factors, evidence was inconclusive, although evidence suggests that age, marital status, education, ethnicity, hospital/region, sleep, smoking, alcohol, surgery, treatment, tumor location, and recurrence are not important associated factors. Regarding the course of depression, we found inconclusive evidence for all factors, although evidence suggests that gender, age, chemotherapy, pain, disease stage, treatment, and tumor location are not important associated factors. Conclusion Depression at an earlier time point is significantly associated with depression later on. Several sociodemographic and clinical factors seem not to be important factors associated with depression. For other factors, further research is warranted.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Factors associated with depression over time in head and neck cancer patients: A systematic review

et al. 2019

View full text Add to dashboard Cite

show abstract

Barriers to psychosocial oncology service utilization in patients newly diagnosed with head and neck cancer

et al. 2018

Self Cite

View full text Add to dashboard Cite

show abstract

Contribution of psychiatric diagnoses to extent of opioid prescription in the first year post‐head and neck cancer diagnosis: A longitudinal study

et al. 2018

Self Cite

View full text Add to dashboard Cite

Purpose The purpose of this study was to determine, within the first‐year post–head and neck cancer (HNC) diagnosis, the contribution of past and upon HNC psychiatric diagnoses (ie, substance use disorder, major depressive disorder, and anxiety disorder) to the extent (ie, cumulated dose) of opioid prescription. Methods Prospective longitudinal study of 223 consecutive adults (on 313 approached; 72% participation) newly diagnosed (<2 weeks) with a first occurrence of primary HNC, including Structured Clinical Interviews for DSM‐IV disorders, validated psychometric measures, and medical chart reviews. Opioid doses were translated into standardized morphine milligram equivalents (MME) using CDC guidelines. A model of variables was tested using multiple linear regression. Results Fifty‐five percent (123/223) of patients received opioids at some point during the first 12 months post–HNC diagnosis, 37.7% (84/223) upon HNC diagnosis (pre‐treatment), 40.8% (91/223) during treatments, and 31.4% (70/223) post‐treatment. The multiple linear regression indicated that an AD (P = 0.04) upon HNC diagnosis in early stage contributes to cumulated MME dose in the first year post–HNC diagnosis. Conclusion This study underlines how anxiety has important repercussions on the management of pain and illustrates the importance of screening for AD upon HNC diagnosis to allow for early prophylactic treatment and support.

show abstract

A screening algorithm for early detection of major depressive disorder in head and neck cancer patients post‐treatment: Longitudinal study

Cited by 20 publications

References 45 publications

Factors associated with depression over time in head and neck cancer patients: A systematic review

Factors associated with depression over time in head and neck cancer patients: A systematic review

Barriers to psychosocial oncology service utilization in patients newly diagnosed with head and neck cancer

Contribution of psychiatric diagnoses to extent of opioid prescription in the first year post‐head and neck cancer diagnosis: A longitudinal study

Contact Info

Product

Resources

About